Evidence map›Paper›PMID 41185798›Full record

ReviewCureus2025

Exploring the Extent of Variance in the Development, Prognosis, and Outcome Between Primary and Secondary Cardiac Tumours: A Systematic Review.

Aahana Nigam, Sandeep Sekar Lakshmisai, Priyanka Sakarkar, Roshitha S Bheemaneni, Evangeline C Nwachukwu, Pousette F Hamid

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Aahana NigamCardiology, Trinity College Dublin, Dublin, IRL.
Sandeep Sekar LakshmisaiDepartment of Medicine, SRM Prime Hospital, Chennai, IND.
Priyanka SakarkarGeneral Surgery, Princess Royal University Hospital, Orpington, GBR.
Roshitha S BheemaneniGastroenterology, AdventHealth Ocala, Ocala, USA.
Evangeline C NwachukwuHealth Emergency Preparedness and Response Department, Nigeria Centre for Disease Control, Abuja, NGA.
Pousette F HamidNeurology, Ain Shams University, Cairo, EGY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review highlights the role of genetics and cellular changes within cardiac muscle in explaining the low prevalence of cardiac tumours, and the preferential development of specific neoplastic subtypes as compared to others. The varying features of primary and secondary cardiac neoplasms are highlighted, with an extended focus on the paediatric population. By analysing past literature, medical interventions, prognostic outcomes, and pathophysiological mechanisms behind cardiac neoplasms are identified. The review adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and employed a thorough Medical Subject Headings (MeSH) search; 18 studies were included in the final analysis. We applied our inclusion criteria to retrieve studies in the English language published from 2000 to 2025. This review primarily includes human studies, with some evidence from animal studies, which were peer-reviewed and are available as full texts. Overall data on 628 patients with cardiac neoplasms were included to discuss the divergent properties of primary cardiac tumours (PCTs) and metastatic cardiac tumours (MCTs). The paper discusses the properties of cellular division within cardiac cells and analyses the properties of muscle cells to explain the mechanism behind the low prevalence of cardiac cancers.

Indexed as

cardiac tumour prognosismetastatic cardiac tumourspaediatric cardiac tumoursprimary cardiac tumourstumour microenvironment

Identifiers

PMID41185798
PMCPMC12579815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.